MEDP Medpace Holdings Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: MEDP

Price (delayed)

$381.71

Market cap

$11.83B

P/E Ratio

34.64

Dividend/share

N/A

EPS

$11.02

Enterprise value

$11.45B

Medpace is a scientifically-driven, global, full-service clinical contract research organization (CRO) providing Phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. Medpace's mission is to accelerate ...

Highlights
Medpace Holdings's quick ratio has surged by 122% YoY and by 14% QoQ
Medpace Holdings's equity has soared by 95% YoY and by 14% from the previous quarter
The P/E is 10% higher than the 5-year quarterly average of 31.5
Medpace Holdings's gross margin has decreased by 2.4% YoY
Sector: Healthcare
Industry: Diagnostics & Research
Website: http://www.medpace.com
Peers: OMGA ONCT

Key stats

What are the main financial stats of MEDP
Market
Shares outstanding
31M
Market cap
$11.83B
Enterprise value
$11.45B
Valuations
Price to earnings (P/E)
34.64
Price to book (P/B)
15.49
Price to sales (P/S)
5.83
EV/EBIT
29.69
EV/EBITDA
26.31
EV/Sales
5.64
Earnings
Revenue
$2.03B
EBIT
$385.85M
EBITDA
$435.37M
Free cash flow
$502.8M
Per share
EPS
$11.02
Free cash flow per share
$16.22
Book value per share
$24.65
Revenue per share
$65.51
TBVPS
$39.45
Balance sheet
Total assets
$1.92B
Total liabilities
$1.16B
Debt
$131.8M
Equity
$763.6M
Working capital
-$120.57M
Liquidity
Debt to equity
0.17
Current ratio
0.88
Quick ratio
0.82
Net debt/EBITDA
-0.87
Margins
EBITDA margin
21.4%
Gross margin
28.5%
Net margin
16.7%
Operating margin
18.8%
Efficiency
Return on assets
19.8%
Return on equity
55.1%
Return on invested capital
N/A
Return on capital employed
41.6%
Return on sales
19%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

MEDP stock price

How has the Medpace Holdings stock price performed over time
Intraday
0.32%
1 week
-9.4%
1 month
-5.83%
1 year
48.8%
YTD
24.53%
QTD
-7.32%

Financial performance

How have Medpace Holdings's revenue and profit performed over time
Revenue
$2.03B
Gross profit
$578.98M
Operating income
$381.45M
Net income
$339.79M
Gross margin
28.5%
Net margin
16.7%
The net income has increased by 26% YoY and by 9% from the previous quarter
MEDP's revenue is up by 21% year-on-year and by 3.4% since the previous quarter
The operating income has increased by 20% year-on-year and by 8% since the previous quarter
MEDP's gross profit is up by 18% year-on-year and by 5% since the previous quarter

Growth

What is Medpace Holdings's growth rate over time

Valuation

What is Medpace Holdings stock price valuation
MEDP P/E details
P/E
34.64
P/B
15.49
P/S
5.83
EV/EBIT
29.69
EV/EBITDA
26.31
EV/Sales
5.64
The EPS is up by 27% YoY and by 8% QoQ
The P/E is 10% higher than the 5-year quarterly average of 31.5
Medpace Holdings's equity has soared by 95% YoY and by 14% from the previous quarter
MEDP's price to book (P/B) is 40% higher than its 5-year quarterly average of 11.0 but 9% lower than its last 4 quarters average of 16.9
MEDP's revenue is up by 21% year-on-year and by 3.4% since the previous quarter
MEDP's price to sales (P/S) is 21% more than its 5-year quarterly average of 4.8 and 8% more than its last 4 quarters average of 5.4

Efficiency

How efficient is Medpace Holdings business performance
The company's return on equity fell by 24% YoY and by 8% QoQ
The ROS is up by 4.4% QoQ

Dividends

What is MEDP's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for MEDP.

Financial health

How did Medpace Holdings financials performed over time
The company's total assets is 66% higher than its total liabilities
Medpace Holdings's quick ratio has surged by 122% YoY and by 14% QoQ
Medpace Holdings's current ratio has surged by 100% YoY and by 13% QoQ
The debt is 83% smaller than the equity
Medpace Holdings's equity has soared by 95% YoY and by 14% from the previous quarter
MEDP's debt to equity has dropped by 66% year-on-year and by 15% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.